Colombia vs Rwanda: Death rate from Alzheimer's
Colombia
7.42 deaths per 100,000 people
in 2021
Rwanda
7.48 deaths per 100,000 people
in 2021
Colombia rank
111th
Rwanda rank
110th
Death rate from Alzheimer's over time
- Colombia
- Rwanda
How they compare
Rwanda currently reports 7.48 deaths per 100,000 people against 7.42 deaths per 100,000 people in Colombia, a difference of 0.06 deaths per 100,000 people.
Across all 22 years both countries report, Rwanda has been ahead every year.
Colombia ranks 111th and Rwanda ranks 110th of 194 countries.
Rwanda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Colombia | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.508 deaths per 100,000 people | 7.08 deaths per 100,000 people | 6.57 deaths per 100,000 people | Rwanda |
| 2010s | 2.54 deaths per 100,000 people | 9.11 deaths per 100,000 people | 6.57 deaths per 100,000 people | Rwanda |
| 2020s | 6.88 deaths per 100,000 people | 7.53 deaths per 100,000 people | 0.645 deaths per 100,000 people | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from alzheimer's, Colombia or Rwanda?
- Rwanda, at 7.48 deaths per 100,000 people against 7.42 deaths per 100,000 people in Colombia as of 2021.
- What is the difference in death rate from alzheimer's between Colombia and Rwanda?
- 0.06 deaths per 100,000 people, with Rwanda ahead.
- How many years of comparable data are there for Colombia and Rwanda?
- 22 years are reported by both, from 2000 to 2021.
- How do Colombia and Rwanda rank globally for death rate from alzheimer's?
- Colombia ranks 111th and Rwanda ranks 110th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from Alzheimer's. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from alzheimer disease and other dementias in both sexes, per 100,000 people.